Em meio a uma das piores ondas de dengue da história recente, o Brasil se vê diante de um paradoxo doloroso: doses de vacina disponíveis, ciência comprovada, necessidade urgente — e ainda assim, hesitação. O Ministério da Saúde ampliou a faixa etária elegível para a vacinação, de 10 a 11 anos para 10 a 14 anos, não por falta de planejamento, mas porque a confiança pública ainda não acompanhou o ritmo da crise. É um lembrete de que, na saúde coletiva, a eficácia de uma vacina nunca é apenas científica — é também humana.
O Imparcial
· Mar 09, 2024
· health
· 2 min read
High
Sourcing: Verified
Brazil expands dengue vaccine eligibility to teens 12-14 as uptake lags
Children and adolescents aged 10-14 represent the highest dengue hospitalization group after elderly, with 16,400 hospitalizations recorded between January 2019 and November 2023.
◉
Health & Medicine
2808 related articles
Ozempic and GLP-1 drugs: how the weight-loss revolution works and what…
O GLOBO · 99% match
Eli Lilly's retatrutida shows 28% weight loss in trials, rivaling bari…
Poder360 · 90% match
GLP-1 drugs like Ozempic expand beyond weight loss into Alzheimer's, h…
Folha de S.Paulo · 90% match
Medical Expert Warns of Tirzepatide Risks, Emphasizes Need for Profess…
UNIPAR · 90% match
Berlin admits American Ebola patient as outbreak kills 131 in Congo
Folha de S.Paulo · 90% match
Related Coverage
Diário de Petrópolis · Aug 24
Dengue, zika, chikungunya e Oropouche: diferenças e riscos da automedicação
Arboviroses apresentam sintomas semelhantes mas evoluções distintas; automedicação com anti-inflamatórios pode agravar d…
ZAP Notícias · Aug 23 Proximidade de lavandarias a seco pode aumentar risco de ParkinsonEstudo com dados de Medicare sugere que viver a menos de 152 metros de lavandarias a seco está associado a 14% maior pro…
TVBV ONLINE · Aug 23 Uso inadequado de zolpidem acende alerta sobre riscos do remédio para insôniaEspecialistas alertam sobre riscos do zolpidem, medicamento popular para insônia no Brasil, que pode causar dependência …
en.com.br · Aug 23 Calor extremo em Cuiabá aumenta risco de pedra nos rins sem hidratação adequadaAltas temperaturas em Cuiabá favorecem desidratação e aumentam concentração de substâncias na urina, elevando o risco de…
Bias & Framing
No detailed analysis data available for this lens. Try re-running lenses from the admin panel.
Geopolitical Impact
🌎
Brazil expands dengue vaccination to ages 12-14 to address low uptake and prevent dose expiration, reflecting domestic public health challenges rather than geopolitical shifts.
Escalation Risk
low
Confidence
HIGH
Brazil
Latin America
Minimal international implications. Demonstrates Brazil's capacity to adapt vaccination strategies independently. Highlights reliance on private pharmaceutical partnerships (Qdenga manufacturer) alongside public health infrastructure, with no significant shift in regional power dynamics.
Similar to Brazil's successful yellow fever vaccination campaigns that established the country as a regional public health leader, though current dengue rollout faces implementation challenges.
Economic Lens
📈
Brazil expands dengue vaccination to ages 10-14 to address low uptake and prevent dose expiration, targeting high-hospitalization age group with 80% efficacy vaccine.
Market Signal
mixed
Confidence
MED
Healthcare and pharmaceuticals
Public health services
Vaccine manufacturing and distribution
Medical devices and diagnostics
Households with children aged 10-14 gain expanded access to dengue prevention, reducing healthcare costs from hospitalizations. However, low initial uptake suggests vaccine hesitancy or awareness challenges that may persist despite expanded eligibility.
Government may need to increase public awareness campaigns and address vaccine hesitancy. Potential for regulatory review of vaccine distribution efficiency. Possible expansion to other age groups or regions if uptake improves. Municipal-private partnerships (like Dourados model) may be encouraged as alternative delivery mechanisms.